+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Analgesics in Brazil

  • PDF Icon

    Report

  • 30 Pages
  • March 2024
  • Region: Brazil
  • Euromonitor International
  • ID: 4417272
Analgesics is set to maintain steady current value growth in Brazil in 2023, and will remain the largest category within OTC, with a 40% share of value sales. The consumption of analgesics is mainly related to general pain, fever, and the relief of hangover symptoms caused by excessive consumption of alcoholic beverages. However, as a mature category, its pace of growth is expected to be lower than most other consumer health categories in 2023.

The Analgesics in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

ANALGESICS IN BRAZILKEY DATA FINDINGS2023 DEVELOPMENTS
Growth remains steady, and analgesics remains the leader within OTC
  • Traditional brands continue to invest in mass media to maintain relevance amongst consumers
  • Small pharmacies still concentrate most sales of analgesics
PROSPECTS AND OPPORTUNITIES
  • Brazilians’ hectic routines will tend to maintain high levels of stress, driving demand for analgesics
  • Distribution developments, with debate set to continue over expanding retail channels
  • Increased awareness of risks of self-medication, and dengue may lead to more cautious consumption of analgesics
CATEGORY DATA
  • Table 1 Sales of Analgesics by Category: Value 2018-2023
  • Table 2 Sales of Analgesics by Category: % Value Growth 2018-2023
  • Table 3 NBO Company Shares of Analgesics: % Value 2019-2023
  • Table 4 LBN Brand Shares of Analgesics: % Value 2020-2023
  • Table 5 Forecast Sales of Analgesics by Category: Value 2023-2028
  • Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2023-2028
CONSUMER HEALTH IN BRAZIL
EXECUTIVE SUMMARY
  • Consumer health in 2023: The big picture
  • 2023 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?
MARKET INDICATORS
  • Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
  • Table 8 Life Expectancy at Birth 2018-2023
MARKET DATA
  • Table 9 Sales of Consumer Health by Category: Value 2018-2023
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2018-2023
  • Table 11 NBO Company Shares of Consumer Health: % Value 2019-2023
  • Table 12 LBN Brand Shares of Consumer Health: % Value 2020-2023
  • Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2018-2023
  • Table 14 Distribution of Consumer Health by Format: % Value 2018-2023
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2023
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2023-2028
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
DISCLAIMERDEFINITIONS
SOURCES
  • Summary 1 Research Sources